Asante Capital congratulates partner HighLight Capital (HLC) on the final closing of its flagship HLC USD Fund IV at US$550 million
We are delighted to share that HighLight Capital (HLC), a private equity firm focusing on venture and growth investments across healthcare and consumer health sectors in China, held the final close of its flagship HLC USD Fund IV at US$550 million.
Asante Capital Group Celebrates 2023 Achievements, Extends Track Record of Successful Fundraises and Grows Global Team
As we enter 2024, Asante is pleased to announce another exceptional year, extending our track record of successful fundraising, strengthening our global presence and offerings, and facilitating expert discussions throughout 2023.
Asante Capital congratulates partner Abingworth on the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million
We are delighted to share that Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million.
Asante Capital congratulates its partner Norvestor on closing Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion
We are delighted to share that Norvestor, a leading private equity firm in the Nordics, has closed Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion, exceeding its €1.25 billion target, despite a challenging fundraising environment.
Asante is excited to announce the global expansion of our secondaries business
Asante is excited to announce that Director Sam Cantor is relocating to our New York City office, further strengthening the global expansion of our secondaries business.